Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B

被引:3
|
作者
Rossetti, B. [1 ]
Bianco, C. [1 ]
De Luca, A. [1 ]
机构
[1] Univ Siena, Policlin Le Scotte, Div Infect Dis 2, I-53100 Siena, Italy
关键词
ACTIVE ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; COINFECTION; PATIENT; HBV;
D O I
10.1007/s15010-011-0198-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:347 / 349
页数:3
相关论文
共 50 条
  • [1] Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report
    Delicio, Adriane Maira
    Martins Abati, Paulo Afonso
    Vigani, Aline Gonzalez
    JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES, 2013, 19
  • [2] Current treatment for chronic hepatitis C virus/HIV-infected individuals: the role of pegylated interferon-alpha and ribavirin
    Bhagani, Sanjay
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (06) : 483 - 490
  • [3] THE COURSE AND TREATMENT OF CHRONIC HEPATITIS B IN HIV-INFECTED PATIENTS
    Maksimov, S. L.
    Tsarenko, S. P.
    Kravchenko, A. V.
    Yushchuk, N. D.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (11) : 32 - 37
  • [4] Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe
    Soriano, Vincent
    Mocroft, Amanda
    Peters, Lars
    Rockstroh, Juergen
    Antunes, Francisco
    Kirkby, Nikolai
    de Wit, Stephane
    Monforte, Antonella d'Arminio
    Flisiak, Robert
    Lundgren, Jens
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (03) : 548 - 555
  • [5] Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment
    Henry Lik-Yuen Chan
    May-Ling Wong
    Alex Yui Hui
    Angel Mei-Ling Chim
    Ada Mei-Ling Tse
    Lawrence Cheung-Tsui Hung
    Francis Ka-Leung Chan
    Joseph Jao-Yiu Sung
    World Journal of Gastroenterology, 2003, 9 (12) : 2695 - 2697
  • [6] Results of Treatment of Chronic Hepatitis B with Pegylated Interferon
    Vigano, Mauro
    Mangia, Giampaolo
    Lampertico, Pietro
    CLINICS IN LIVER DISEASE, 2013, 17 (03) : 425 - +
  • [7] Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin
    Potthoff, A.
    Berg, T.
    Wedemeyer, H.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (12) : 1487 - 1490
  • [8] Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients
    Honge, B. L.
    Jespersen, S.
    Medina, C.
    Te, D. S.
    da Silva, Z. J.
    Ostergaard, L.
    Laursen, A. L.
    Wejse, C.
    Krarup, H.
    Erikstrup, C.
    HIV MEDICINE, 2014, 15 (09) : 571 - 576
  • [9] Pegylated interferon α2a plus ribavirin versus pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Berenguer, J.
    Gonzalez-Garcia, J.
    Lopez-Aldeguer, J.
    Von-Wichmann, M. A.
    Quereda, C.
    Hernando, A.
    Sanz, J.
    Tural, C.
    Ortega, E.
    Mallolas, J.
    Santos, I.
    Miralles, P.
    Montes, M. L.
    Bellon, J. M.
    Esteban, H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (06) : 1256 - 1263
  • [10] Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine
    Marcellin, Patrick
    Lada, Olivier
    Asselah, Tarik
    HEPATOLOGY RESEARCH, 2007, 37 : S55 - S61